AMED logo

Amedisys (AMED) Cash From Financing

Annual CFF

-$87.52 M
-$57.09 M-187.59%

December 31, 2023


Summary


Performance

AMED Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAMEDcash flowmetrics:

Quarterly CFF

-$15.09 M
-$1.01 M-7.15%

September 30, 2024


Summary


Performance

AMED Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAMEDcash flowmetrics:

TTM CFF

-$51.14 M
-$8.83 M-20.88%

September 30, 2024


Summary


Performance

AMED TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAMEDcash flowmetrics:

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

AMED Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-187.6%-7.2%-20.9%
3 y3 years-484.4%+73.5%+36.0%
5 y5 years+67.3%+73.5%+36.0%

AMED Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-258.8%at low-471.3%+80.1%-133.9%+43.5%
5 y5-year-138.5%at low-106.3%+89.7%-122.5%+85.4%
alltimeall time-129.0%+67.3%-103.9%+89.7%-113.2%+85.4%

Amedisys Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
-$15.09 M(+7.2%)
-$51.14 M(+20.9%)
Jun 2024
-
-$14.08 M(+64.7%)
-$42.31 M(+8.0%)
Mar 2024
-
-$8.55 M(-36.3%)
-$39.18 M(-55.2%)
Dec 2023
-$87.52 M(+187.6%)
-$13.43 M(+114.7%)
-$87.52 M(-3.2%)
Sep 2023
-
-$6.25 M(-42.9%)
-$90.44 M(+4.2%)
Jun 2023
-
-$10.95 M(-80.7%)
-$86.83 M(+8.6%)
Mar 2023
-
-$56.89 M(+248.1%)
-$79.92 M(+162.6%)
Dec 2022
-$30.43 M(-155.2%)
-$16.34 M(+518.9%)
-$30.43 M(-66.2%)
Sep 2022
-
-$2.64 M(-34.7%)
-$90.03 M(-159.6%)
Jun 2022
-
-$4.05 M(-45.3%)
$150.97 M(+43.5%)
Mar 2022
-
-$7.40 M(-90.3%)
$105.18 M(+90.8%)
Dec 2021
$55.13 M(-468.1%)
-$75.94 M(-131.9%)
$55.13 M(+59.2%)
Sep 2021
-
$238.36 M(-578.3%)
$34.62 M(-109.9%)
Jun 2021
-
-$49.83 M(-13.3%)
-$350.47 M(+60.4%)
Mar 2021
-
-$57.46 M(-40.4%)
-$218.48 M(+1358.8%)
Dec 2020
-$14.98 M(-106.6%)
-$96.44 M(-34.3%)
-$14.98 M(-118.0%)
Sep 2020
-
-$146.74 M(-278.6%)
$83.36 M(-56.8%)
Jun 2020
-
$82.16 M(-43.7%)
$193.10 M(+160.7%)
Mar 2020
-
$146.04 M(+7590.5%)
$74.07 M(-67.4%)
Dec 2019
$227.21 M(-185.0%)
$1.90 M(-105.1%)
$227.21 M(+28.3%)
Sep 2019
-
-$37.00 M(+0.3%)
$177.07 M(+25.5%)
Jun 2019
-
-$36.87 M(-112.3%)
$141.11 M(+301.1%)
Mar 2019
-
$299.18 M(-720.2%)
$35.18 M(-113.2%)
Dec 2018
-$267.42 M(+4728.9%)
-$48.24 M(-33.9%)
-$267.42 M(+21.6%)
Sep 2018
-
-$72.96 M(-48.9%)
-$219.99 M(+47.8%)
Jun 2018
-
-$142.80 M(+4063.1%)
-$148.84 M(+1718.9%)
Mar 2018
-
-$3.43 M(+322.9%)
-$8.18 M(+47.8%)
Dec 2017
-$5.54 M(-26.3%)
-$811.00 K(-55.0%)
-$5.54 M(+3.4%)
Sep 2017
-
-$1.80 M(-15.9%)
-$5.36 M(+42.4%)
Jun 2017
-
-$2.14 M(+172.7%)
-$3.76 M(-64.3%)
Mar 2017
-
-$785.00 K(+24.6%)
-$10.53 M(+40.1%)
Dec 2016
-$7.51 M(-64.0%)
-$630.00 K(+204.3%)
-$7.51 M(-15.7%)
Sep 2016
-
-$207.00 K(-97.7%)
-$8.92 M(+18.5%)
Jun 2016
-
-$8.91 M(-499.2%)
-$7.53 M(+458.7%)
Mar 2016
-
$2.23 M(-209.9%)
-$1.35 M(-93.6%)
Dec 2015
-$20.89 M(-129.6%)
-$2.03 M(-271.7%)
-$20.89 M(+32.0%)
Sep 2015
-
$1.18 M(-143.3%)
-$15.83 M(-67.2%)
Jun 2015
-
-$2.73 M(-84.2%)
-$48.27 M(-185.5%)
Mar 2015
-
-$17.32 M(-670.9%)
$56.45 M(-20.0%)
Dec 2014
$70.56 M(-233.0%)
$3.03 M(-109.7%)
$70.56 M(+61.1%)
Sep 2014
-
-$31.25 M(-130.6%)
$43.81 M(-39.1%)
Jun 2014
-
$101.99 M(-3286.1%)
$71.93 M(-317.1%)
Mar 2014
-
-$3.20 M(-86.5%)
-$33.13 M(-37.5%)
Dec 2013
-$53.05 M(+23.5%)
-$23.72 M(+656.4%)
-$53.05 M(+6.6%)
Sep 2013
-
-$3.14 M(+2.0%)
-$49.77 M(-8.1%)
Jun 2013
-
-$3.07 M(-86.7%)
-$54.13 M(-7.5%)
Mar 2013
-
-$23.11 M(+13.1%)
-$58.49 M(+36.1%)
Dec 2012
-$42.96 M(+31.0%)
-$20.45 M(+172.8%)
-$42.96 M(+48.9%)
Sep 2012
-
-$7.50 M(+0.8%)
-$28.84 M(-6.0%)
Jun 2012
-
-$7.43 M(-2.1%)
-$30.67 M(-5.2%)
Mar 2012
-
-$7.59 M(+19.9%)
-$32.34 M(-1.4%)
Dec 2011
-$32.79 M(-30.0%)
-$6.33 M(-32.1%)
-$32.79 M(-8.7%)
Sep 2011
-
-$9.32 M(+2.4%)
-$35.91 M(-24.8%)
Jun 2011
-
-$9.11 M(+13.3%)
-$47.78 M(+4.5%)
Mar 2011
-
-$8.04 M(-15.0%)
-$45.71 M(-2.4%)
Dec 2010
-$46.85 M(-60.6%)
-$9.45 M(-55.4%)
-$46.85 M(+5.7%)
Sep 2010
-
-$21.19 M(+201.4%)
-$44.32 M(+0.3%)
Jun 2010
-
-$7.03 M(-23.4%)
-$44.21 M(-60.3%)
Mar 2010
-
-$9.18 M(+32.4%)
-$111.32 M(-6.3%)
Dec 2009
-$118.77 M
-$6.93 M(-67.1%)
-$118.77 M(-16.2%)
DateAnnualQuarterlyTTM
Sep 2009
-
-$21.08 M(-71.6%)
-$141.75 M(+3.5%)
Jun 2009
-
-$74.14 M(+346.2%)
-$136.93 M(+36.6%)
Mar 2009
-
-$16.62 M(-44.4%)
-$100.26 M(-133.2%)
Dec 2008
$301.57 M(+9300.5%)
-$29.91 M(+84.0%)
$301.57 M(-9.3%)
Sep 2008
-
-$16.25 M(-56.6%)
$332.54 M(-4.6%)
Jun 2008
-
-$37.48 M(-109.7%)
$348.74 M(-10.0%)
Mar 2008
-
$385.21 M(>+9900.0%)
$387.46 M(>+9900.0%)
Dec 2007
$3.21 M(-95.5%)
$1.06 M(-2130.8%)
$3.21 M(-95.8%)
Sep 2007
-
-$52.00 K(-104.2%)
$77.20 M(+0.4%)
Jun 2007
-
$1.25 M(+30.3%)
$76.93 M(+17.5%)
Mar 2007
-
$957.00 K(-98.7%)
$65.47 M(-9.0%)
Dec 2006
$71.97 M(+47.7%)
$75.05 M(<-9900.0%)
$71.97 M(-656.0%)
Sep 2006
-
-$326.00 K(-96.8%)
-$12.94 M(-128.3%)
Jun 2006
-
-$10.22 M(-236.9%)
$45.68 M(-19.0%)
Mar 2006
-
$7.46 M(-175.7%)
$56.42 M(+15.8%)
Dec 2005
$48.71 M(-25.8%)
-$9.86 M(-116.9%)
$48.71 M(-13.9%)
Sep 2005
-
$58.30 M(>+9900.0%)
$56.58 M(-15.5%)
Jun 2005
-
$518.00 K(-312.3%)
$66.92 M(+1.6%)
Mar 2005
-
-$244.00 K(-87.8%)
$65.85 M(+0.2%)
Dec 2004
$65.69 M(+473.4%)
-$2.00 M(-102.9%)
$65.69 M(-19.9%)
Sep 2004
-
$68.64 M(<-9900.0%)
$81.97 M(+482.1%)
Jun 2004
-
-$545.00 K(+33.9%)
$14.08 M(+11.3%)
Mar 2004
-
-$407.00 K(-102.9%)
$12.65 M(+10.5%)
Dec 2003
$11.46 M(-234.0%)
$14.28 M(+1788.4%)
$11.46 M(-220.3%)
Sep 2003
-
$756.00 K(-138.4%)
-$9.53 M(-4.7%)
Jun 2003
-
-$1.97 M(+22.7%)
-$9.99 M(+293.2%)
Mar 2003
-
-$1.60 M(-76.1%)
-$2.54 M(-70.3%)
Dec 2002
-$8.55 M(-179.4%)
-$6.71 M(-2404.8%)
-$8.55 M(-279.7%)
Sep 2002
-
$291.00 K(-94.7%)
$4.76 M(-10.4%)
Jun 2002
-
$5.48 M(-172.0%)
$5.32 M(-1576.4%)
Mar 2002
-
-$7.62 M(-215.3%)
-$360.00 K(-103.3%)
Dec 2001
$10.78 M(-231.7%)
$6.61 M(+680.7%)
$10.78 M(-404.9%)
Sep 2001
-
$846.00 K(-533.8%)
-$3.53 M(-31.7%)
Jun 2001
-
-$195.00 K(-105.5%)
-$5.17 M(+83.2%)
Mar 2001
-
$3.52 M(-145.7%)
-$2.82 M(-65.5%)
Dec 2000
-$8.18 M(-174.6%)
-$7.70 M(+872.7%)
-$8.18 M(+1611.7%)
Sep 2000
-
-$792.00 K(-136.8%)
-$478.00 K(-252.2%)
Jun 2000
-
$2.15 M(-217.1%)
$314.00 K(-117.1%)
Mar 2000
-
-$1.84 M(-117.7%)
-$1.84 M(-165.3%)
Dec 1999
$10.96 M(-250.2%)
-
-
Mar 1999
-
$10.42 M(-161.6%)
$2.82 M(-138.6%)
Dec 1998
-$7.30 M(-236.5%)
-$16.90 M(-381.6%)
-$7.30 M(-155.1%)
Sep 1998
-
$6.00 M(+81.8%)
$13.25 M(+85.3%)
Jun 1998
-
$3.30 M(+1000.0%)
$7.15 M(+53.8%)
Mar 1998
-
$300.00 K(-91.8%)
$4.65 M(-13.1%)
Dec 1997
$5.35 M(+37.8%)
$3.65 M(-3749.0%)
$5.35 M(+53.6%)
Sep 1997
-
-$100.00 K(-112.5%)
$3.48 M(-5.4%)
Jun 1997
-
$800.00 K(-20.0%)
$3.68 M(-7.5%)
Mar 1997
-
$1.00 M(-43.9%)
$3.98 M(+2.6%)
Dec 1996
$3.88 M(-1070.5%)
$1.78 M(+1682.0%)
$3.88 M(+21.3%)
Sep 1996
-
$100.00 K(-90.9%)
$3.20 M(+39.1%)
Jun 1996
-
$1.10 M(+22.2%)
$2.30 M(+283.3%)
Mar 1996
-
$900.00 K(-18.2%)
$600.00 K(-250.0%)
Dec 1995
-$400.00 K(-130.8%)
$1.10 M(-237.5%)
-$400.00 K(-73.3%)
Sep 1995
-
-$800.00 K(+33.3%)
-$1.50 M(+114.3%)
Jun 1995
-
-$600.00 K(+500.0%)
-$700.00 K(<-9900.0%)
Mar 1995
-
-$100.00 K(-200.0%)
$0.00(-100.0%)
Dec 1994
$1.30 M(0.0%)
-
-
Jun 1994
-
$100.00 K(-80.0%)
$600.00 K(+20.0%)
Mar 1994
-
$500.00 K
$500.00 K
Dec 1993
$1.30 M
-
-

FAQ

  • What is Amedisys annual cash flow from financing activities?
  • What is the all time high annual CFF for Amedisys?
  • What is Amedisys annual CFF year-on-year change?
  • What is Amedisys quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Amedisys?
  • What is Amedisys quarterly CFF year-on-year change?
  • What is Amedisys TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Amedisys?
  • What is Amedisys TTM CFF year-on-year change?

What is Amedisys annual cash flow from financing activities?

The current annual CFF of AMED is -$87.52 M

What is the all time high annual CFF for Amedisys?

Amedisys all-time high annual cash flow from financing activities is $301.57 M

What is Amedisys annual CFF year-on-year change?

Over the past year, AMED annual cash flow from financing activities has changed by -$57.09 M (-187.59%)

What is Amedisys quarterly cash flow from financing activities?

The current quarterly CFF of AMED is -$15.09 M

What is the all time high quarterly CFF for Amedisys?

Amedisys all-time high quarterly cash flow from financing activities is $385.21 M

What is Amedisys quarterly CFF year-on-year change?

Over the past year, AMED quarterly cash flow from financing activities has changed by -$1.01 M (-7.15%)

What is Amedisys TTM cash flow from financing activities?

The current TTM CFF of AMED is -$51.14 M

What is the all time high TTM CFF for Amedisys?

Amedisys all-time high TTM cash flow from financing activities is $387.46 M

What is Amedisys TTM CFF year-on-year change?

Over the past year, AMED TTM cash flow from financing activities has changed by -$8.83 M (-20.88%)